Cargando…
Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis
BACKGROUND: Mild cognitive impairment (MCI) is an intermediate state between normal aging and dementia including Alzheimer’s disease. Early detection of dementia, and MCI, is a crucial issue in terms of secondary prevention. Blood biomarker detection is a possible way for early detection of MCI. Alt...
Autores principales: | Kayano, Mitsunori, Higaki, Sayuri, Satoh, Jun-ichi, Matsumoto, Kenji, Matsubara, Etsuro, Takikawa, Osamu, Niida, Shumpei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151129/ https://www.ncbi.nlm.nih.gov/pubmed/27999671 http://dx.doi.org/10.1186/s40364-016-0076-1 |
Ejemplares similares
-
Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models
por: Higaki, Sayuri, et al.
Publicado: (2018) -
MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis
por: Mori, Taiki, et al.
Publicado: (2017) -
JAMIR-eQTL: Japanese genome-wide identification of microRNA expression
quantitative trait loci across dementia types
por: Akiyama, Shintaro, et al.
Publicado: (2021) -
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer’s Disease from Public Data
por: Satoh, Jun-ichi, et al.
Publicado: (2015) -
Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data
por: Shigemizu, Daichi, et al.
Publicado: (2020)